PUBLIC COMPANY
savePhytoHealth Corp
updated 4mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —Study of PHN131 in Healthy Volunteers
- phase2Effects of PH3 in Diabetic Nephropathy
- phase2PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
- phase3Study of PHN131 in Patients After Surgery
- phase3PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
- phase2A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
- phase2PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
- phase2Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that